Evidence map›Paper›PMID 36718037›Full record

Observational studyThe journal of international advanced otology2023

Analysis of Prognostic Factors Impacting Pediatric Acute Mastoiditis Outcomes.

Asaf Israeli, Andro Kosec, Isaac Shochat, Gianluca Piras, Itzhak Braverman, Adi Klein, Golda Grinblat

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in The journal of international advanced otology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Asaf IsraeliBruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.
Andro KosecDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Sestre milosrdnice School of Medicine, University of Zagreb, Croatia.
Isaac ShochatDepartment of Otorhinolaryngology, Hillel Yaffe Medical Center, Hadera, Israel.
Gianluca PirasDepartment of Otology and Skull Base Surgery, Gruppo Otologico and Mario Sanna Foundation, Piacenza-Rome, Italy.
Itzhak BravermanBruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa; Department of Otorhinolaryngology, Hillel Yaffe Medical Center, Hadera, Israel.
Adi KleinDepartment of Pediatrics, Hillel Yaffe Medical Center, Hadera, Israel.
Golda GrinblatBruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa; Department of Otorhinolaryngology, Hillel Yaffe Medical Center, Hadera, Israel.
Hillel Yaffe Medical Center · ILFondazione Umberto Di Mario · ITRappaport Family Institute for Research in the Medical Sciences · ILSisters of Charity Hospital · HRTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to investigate the outcomes of pediatric patients with acute mastoiditis while examining the role of intravenous steroid therapy, patient demographics, and serum inflammatory values as prognostic factors.

methodsThis study is a single-center retrospective observational study including 73 consecutive patients treated for acute mastoiditis in the course of the 10-year study period (January 2010 to December 2019).

resultsData analysis showed that patients requiring surgical treatment (14%) had a 3-fold higher C-reactive protein value at admission compared to those treated conservatively (P < .001). Receiver operating characteristic analysis revealed that a C-reactive protein cut-off of ≥98.7 had a sensitivity and specificity of 100% and 74.6%, respectively, for predicting the need for surgery (area under the curve=0.927, P < .001). The duration of symptoms before hospitalization was nearly 2 days shorter in male patients (P=.031), and the use of intravenous steroid therapy significantly shortened the length of hospitalization (P=.023), by 1.4 days on average.

conclusionIntravenous steroid therapy may be useful in decreasing the length of hospital stay. Mastoiditis tends to present more severely in male patients, and monitoring C-reactive protein values during treatment correlated well with the need for surgery.

Indexed as

MastoiditisAcute DiseaseAnti-Bacterial AgentsChildC-Reactive ProteinHospitalizationHumansMalePrognosisRetrospective StudiesAnti-Bacterial AgentsC-Reactive Protein

Identifiers

PMID36718037
PMCPMC9984910
OpenAlexW4316362639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.